Rituximab Beneficial in Secondary Progressive MS

MONDAY, Jan. 7, 2019 — For patients with secondary progressive multiple sclerosis (SPMS), treatment with rituximab is associated with a significantly lower Expanded Disability Status Scale (EDSS) score and delayed progression, according to a study